Sangoma Sells to BRC After Strategic Review, Deal Expected to Close Early 2027
Sangoma shareholders get $4.925 cash plus BRC stock, about $5.23 a share—a 47% premium.
Already have an account? Sign in.
Sangoma shareholders get $4.925 cash plus BRC stock, about $5.23 a share—a 47% premium.
Be the first to know when deals break, stocks move, or biotech headlines hit.